GJA3

Chr 13AD

gap junction protein alpha 3

Also known as: CTRCT14, CX46, CZP3

This gene encodes connexin 43, a structural component of gap junctions that form dodecameric channels connecting the cytoplasm of adjacent lens fiber cells, allowing diffusion of small molecules and ions. Mutations cause autosomal dominant cataracts with multiple morphologic types, including zonular pulverulent cataracts. The gene shows low constraint to loss-of-function variants, consistent with a dominant inheritance pattern affecting lens development and transparency.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 1.491 OMIM phenotype
Clinical SummaryGJA3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
84 unique Pathogenic / Likely Pathogenic· 191 VUS of 347 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.49LOEUF
pLI 0.001
Z-score 0.68
OE 0.72 (0.381.49)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.71Z-score
OE missense 0.70 (0.620.80)
186 obs / 264.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.72 (0.381.49)
00.351.4
Missense OE0.70 (0.620.80)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 5 / 6.9Missense obs/exp: 186 / 264.3Syn Z: 0.87
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGJA3-related cataractOTHERAD
DN
0.81top 10%
GOF
0.86top 5%
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

347 submitted variants in ClinVar

Classification Summary

Pathogenic46
Likely Pathogenic38
VUS191
Likely Benign26
Benign36
Conflicting9
46
Pathogenic
38
Likely Pathogenic
191
VUS
26
Likely Benign
36
Benign
9
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
3
42
0
46
Likely Pathogenic
7
29
2
0
38
VUS
8
115
62
6
191
Likely Benign
1
7
4
14
26
Benign
0
2
27
7
36
Conflicting
9
Total1715613727346

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GJA3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →